Evidence map›Paper›PMID 39700066›Full record

ArticlePLOS digital health2024

A voice-based algorithm can predict type 2 diabetes status in USA adults: Findings from the Colive Voice study.

Abir Elbéji, Mégane Pizzimenti, Gloria Aguayo, Aurélie Fischer, Hanin Ayadi, Franck Mauvais-Jarvis, Jean-Pierre Riveline, Vladimir Despotovic, Guy Fagherazzi

2 registry-linked trialsAbstract read
In one paragraph

Article in PLOS digital health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04848623 recruitingnot on this map

Identification of Vocal Biomarkers to Monitor the Health of People With a Chronic Disease

TypeobservationalSponsorLuxembourg Institute of HealthRan2021 to 2031Enrolled50,000ConditionsChronic Disease
NCT07421921 completednot on this mapstarted 2025, after this paper: background citation

Voice Biomarkers for Type 2 Diabetes Detection: A Two-Stage Validation Study

TypeobservationalSponsorThymia LimitedRan2025 to 2026Enrolled7,319ConditionsType 2 Diabetes, Diabetes (DM), T2DM, T2DM (Type 2 Diabetes Mellitus)
3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Abir ElbéjiDeep Digital Phenotyping Research Unit. Department of Precision Health, Luxembourg Institute of Health, 1 A-B rue Thomas Edison, L-1445 Strassen, Luxembourg.ORCID https://orcid.org/0000-0002-5293-4337
Mégane PizzimentiDeep Digital Phenotyping Research Unit. Department of Precision Health, Luxembourg Institute of Health, 1 A-B rue Thomas Edison, L-1445 Strassen, Luxembourg.
Gloria AguayoDeep Digital Phenotyping Research Unit. Department of Precision Health, Luxembourg Institute of Health, 1 A-B rue Thomas Edison, L-1445 Strassen, Luxembourg.
Aurélie FischerDeep Digital Phenotyping Research Unit. Department of Precision Health, Luxembourg Institute of Health, 1 A-B rue Thomas Edison, L-1445 Strassen, Luxembourg.
Hanin AyadiDeep Digital Phenotyping Research Unit. Department of Precision Health, Luxembourg Institute of Health, 1 A-B rue Thomas Edison, L-1445 Strassen, Luxembourg.
Franck Mauvais-JarvisSection of Endocrinology and Metabolism, Deming Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, United States of America.
Jean-Pierre RivelineInstitut Necker Enfants Malades, Inserm U1151, CNRS UMR 8253, Immediab Laboratory, Paris, France.
Vladimir DespotovicBioinformatics Platform, Luxembourg Institute of Health, 1 A-B rue Thomas Edison, L-1445 Strassen, Luxembourg.
Guy FagherazziDeep Digital Phenotyping Research Unit. Department of Precision Health, Luxembourg Institute of Health, 1 A-B rue Thomas Edison, L-1445 Strassen, Luxembourg.ORCID https://orcid.org/0000-0001-5033-5966

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pressing need to reduce undiagnosed type 2 diabetes (T2D) globally calls for innovative screening approaches. This study investigates the potential of using a voice-based algorithm to predict T2D status in adults, as the first step towards developing a non-invasive and scalable screening method. We analyzed pre-specified text recordings from 607 US participants from the Colive Voice study registered on ClinicalTrials.gov (NCT04848623). Using hybrid BYOL-S/CvT embeddings, we constructed gender-specific algorithms to predict T2D status, evaluated through cross-validation based on accuracy, specificity, sensitivity, and Area Under the Curve (AUC). The best models were stratified by key factors such as age, BMI, and hypertension, and compared to the American Diabetes Association (ADA) score for T2D risk assessment using Bland-Altman analysis. The voice-based algorithms demonstrated good predictive capacity (AUC = 75% for males, 71% for females), correctly predicting 71% of male and 66% of female T2D cases. Performance improved in females aged 60 years or older (AUC = 74%) and individuals with hypertension (AUC = 75%), with an overall agreement above 93% with the ADA risk score. Our findings suggest that voice-based algorithms could serve as a more accessible, cost-effective, and noninvasive screening tool for T2D. While these results are promising, further validation is needed, particularly for early-stage T2D cases and more diverse populations.

Identifiers

PMID39700066
PMCPMC11658629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.